ShermanGraham8: Updated article with clearer structure

2025-10-13T20:53:31Z

Updated article with clearer structure

imported>Rsrikanth05 at 10:04, 30 August 2021

2021-08-30T10:04:33Z

← Older revision		Revision as of 15:34, 30 August 2021
Line 1:		Line 1:
	{{Use dmy dates\|date=August 2018}}		{{Use dmy dates\|date=August 2018}}
	{{Use Indian English\|date=August 2018}}		{{Use Indian English\|date=August 2018}}
			:''Not to be confused with [[Cadila Healthcare]]''
	{{Infobox company		{{Infobox company
	\| name = Cadila Pharmaceuticals Limited		\| name = Cadila Pharmaceuticals Limited

>Asinolii: /* 1995: Birth of Cadila Pharmaceuticals */

2021-06-22T10:35:16Z

1995: Birth of Cadila Pharmaceuticals

New page

{{Use dmy dates|date=August 2018}}
{{Use Indian English|date=August 2018}}
{{Infobox company
| name = Cadila Pharmaceuticals Limited
| logo = Cadila Pharmaceuticals Logo.jpg
| logo_size = 220px
| logo_alt = Cadila_Pharmaceuticals_Logo
| image =
| type = Private company
| foundation = 1951
| founder = [[Indravadan Modi]]
| location_city = [[Ahmedabad]], [[Gujarat]]
| num_employees = 8000
| subsid = IRM Ltd
| location_country = India
| key_people = Dr. Rajiv Modi <br />(Chairman and Managing Director)
| industry = [[Pharmaceutical industry|Pharmaceuticals]]
| products = [[API]]s, [[Generic drug]]s
| services = Contract Research, [[Contract Manufacturing]]
| homepage = {{URL|http://www.cadilapharma.com/}}
}}

'''Cadila Pharmaceuticals''' is an Indian [[multinational corporation|multinational]] pharmaceutical group based in [[Ahmedabad]], [[Gujarat]], India. With more than 6 decades of experience, the company's integrated operations focus on manufacturing products ranging from API's-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products and pharmaceutical Machinery. Cadila Pharmaceuticals manufacturing facilities are approved by International bodies such as WHO-GMP, UK-MHRA, USFDA-API, TGA-Australia, and AIFA-Italy. The company's international operation of is spread across 58 countries including the Americas, Japan, Asia, CIS and Africa.<ref>{{cite web|url=https://www.cphi.com/europe/exhibitors/cadila-pharmaceuticals-ltd|title=Cadila Pharmaceuticals Ltd|date=13 September 2018|website=CPhI Worldwide - Uniting the Pharmaceutical Industry}}</ref>

== History ==
[[File:Indravadan A Modi.jpg|right|thumb|300px|Indravadan Modi, Founder]]
===Cadila Laboratories ===
In 1951 Indravadan A Modi had quit his job as a chemist in a Mumbai firm to start Cadila Laboratories with childhood friend Ramanbhai Patel. The company that started in a rented bungalow with a capital of Rs 25,000 and achieved a turnover of around Rs 1.25 lakh in its first year of operation had come a long way.<ref name="auto">{{cite web|url=https://www.business-standard.com/article/companies/carrying-the-legacy-forward-rajiv-modi-114012801184_1.html|title=Carrying the legacy forward: Rajiv Modi|first=Sohini|last=Das|date=28 January 2014|publisher=|via=Business Standard}}</ref>

=== 1995: Birth of Cadila Pharmaceuticals ===
The Modi and Patel families decided to split the business in 1995, two entities were formed - '''Cadila Pharmaceuticals Ltd''' (owned and controlled by Shri. I A Modi and his son Dr. Rajiv Modi) and [[Cadila Healthcare]] (owned by Shri. Ramanbhai Patel and his son Pankaj Patel family). Rajiv Modi and I A Modi worked closely to run Cadila Pharma, now considered one of the largest privately-held pharma companies in the country.<ref name="auto"/>

== Operations ==
Cadila Pharmaceuticals has its formulation manufacturing facilities at Dholka, Gujarat (India); Samba, Jammu (India) and at Addis Ababa (Ethiopia) and 2 API manufacturing facilities are located at Ankleshwar, Gujarat. The manufacturing facility at Dholka and the API unit at Ankleshwar in Gujarat are USFDA-certified; the overseas manufacturing facility at Ethiopia is the WHO - cGMP compliant facility.<ref>[http://pharma.financialexpress.com/sections/management/1698-caring-cadila Financial Express 28 January 2013]</ref>

== Research ==
Cadila Pharmaceuticals has established a dedicated R&D facility, spread over 1,05,000 sq. ft. area at Dholka, Gujarat, India which is manned by 300 scientists.

The company has five IND dossiers filed with the USFDA for pulmonary tuberculosis, lung cancer, prostate cancer, bladder cancer and melanoma. The company has submitted ten ANDAs.<ref>{{cite web|url=http://www.indiainbusiness.nic.in/economy/pharma.htm|title=Welcome to India in Business|website=www.indiainbusiness.nic.in|access-date=24 March 2014|archive-url=https://web.archive.org/web/20140707164613/http://www.indiainbusiness.nic.in/economy/pharma.htm|archive-date=7 July 2014|url-status=dead}}</ref>
Cadila Pharmaceuticals has connections with various institutions for research; Department of Biotechnology, UDSC, New Delhi; IISc, Bangalore; Lala Ram Sarup Institute of TB & Respiratory diseases, New Delhi; RRL, Jammu; CSIR, New Delhi; CDRI, Lucknow; Advanced Transfusion Medicine Research Foundation, Ahmedabad; National Institute of Immunology, New Delhi; Institute of Microbial Technology, Chandigarh; Talwar Research Foundation, New Delhi and Trieste, Italy.<ref>{{cite web|url=http://cadilapharma.com/index.php/about-us/milestones/|title=Cadila Pharma|publisher=|access-date=24 March 2014|archive-url=https://web.archive.org/web/20140421143024/http://cadilapharma.com/index.php/about-us/milestones/|archive-date=21 April 2014|url-status=dead}}</ref>

== Products and services ==
Cadila Pharmaceuticals is the only Indian manufacturer of natural Streptokinase and Hyaluronic Acid products. The company was also the first in the world to introduce Rabeprazole in IV form – ‘Rabeloc’.<ref>{{cite web|url=https://www.business-standard.com/article/companies/cadila-pharma-unveils-acidity-drug-in-iv-form-104071601136_1.html|title=Cadila Pharma unveils acidity drug in IV form|first=Our Regional|last=Bureau|date=16 July 2004|publisher=|via=Business Standard}}</ref> In 2009, the world’s first boosted-Rifampicin fixed-dose combination for the treatment of Tuberculosis – ‘Risorine’<ref>{{cite web|url=https://www.dnaindia.com/business/report-cadila-launches-new-drug-for-tb-treatment-1305424|title=Cadila launches new drug for TB treatment|date=31 October 2009|website=dna}}</ref> and world's first drug combination for prevention of Cardiovascular Diseases – ‘[http://polycap.org/ Polycap]’ were introduced by Cadila Pharmaceuticals.<ref>{{cite web|url=https://www.financialexpress.com/archive/cadila-pharmaceuticals-launches-polycap-which-reduces-cardiovascular-and-stroke-risk-substantially/442271/|title=Cadila Pharmaceuticals launches Polycap, which reduces cardiovascular and stroke risk substantially|date=2 April 2009|website=The Financial Express}}</ref>
For the patients suffering from Non Small Cell Lung Cancer (NSCLC), company has recently introduced ‘Mycidac-C’ - first in the class active immunotherapy as well as drug targeting Desmocollin.<ref>{{cite web|url=http://articles.economictimes.indiatimes.com/2013-11-21/news/44327154_1_nsclc-small-cell-lung-cancer-drug-controller-general|title=Economic Times 21 November 2013|publisher=}}</ref>
Some of the top brands of the company are Aciloc, Envas, Calcirol, Haem Up, Vasograin, Tricort, Fludac, Rabiloc, Trigan-D, Mycobutol and [[Sepsivac]].

== Alliances ==
In 2019, Cadila Pharmaceuticals formed a partnership with Norwegian start-up, Serca Pharmaceuticals to develop new treatment for heart patients.<ref>{{Cite web|url=https://www.thehindubusinessline.com/companies/cadila-pharma-inks-pact-with-norwegian-start-up-to-develop-new-treatment-for-heart-patients/article25960391.ece|title=Cadila Pharma inks pact with Norwegian start-up to develop new treatment for heart patients|last=Bureau|first=Our|website=@businessline|language=en|access-date=2019-01-11}}</ref>

== Awards and Recognition ==
Most Trusted Companies of 2008, Sara Media and Zee Business<ref>{{Cite web|url=https://www.deshgujarat.com/2012/11/26/indravadan-a-modi-the-medicine-man-of-india/|title=Indravadan A Modi: The medicine man of India|date=2012-11-26|website=DeshGujarat|language=en-US|access-date=2019-10-16}}</ref>

WorldStar Packaging Award, 2018<ref>{{Cite web|url=https://www.worldstar.org/winner/2019/calcirol-softgel-cadila-pharmaceuticals-limited|title=Calcirol Softgel {{!}} Worldstar|website=www.worldstar.org|access-date=2019-10-16}}</ref>

TISS LeapVault CLO Award, 2019<ref>{{Cite web|url=https://www.expresspharma.in/latest-updates/cadila-pharma-bags-tiss-leapvault-clo-awards-in-two-categories/|title=Cadila Pharma bags TISS LeapVault CLO awards in two categories|date=2019-08-09|website=Express Pharma|language=en-US|access-date=2019-10-16}}</ref>

Observenow Future of Workplace Award, 2019<ref>{{Cite web|url=http://thepharmatimes.in/cadila-pharma-wins-observenow-future-of-workplace-award/|title=Cadila Pharma wins ‘ObserveNow Future of Workplace Award’|last=Bureau|first=The Pharma Times News|date=2019-09-14|website=The Pharma Times {{!}} Pharma & Health Care News Portal|language=en-US|access-date=2019-10-16}}</ref>

Great Place to Work Certified, 2020<ref>{{Cite web|url=https://www.theweek.in/wire-updates/business/2020/03/06/pwr6-cadila%20pharmaceuticals.html|title=Cadila Pharmaceuticals Awarded Great Place To Work Certificate|website=The Week|language=en|access-date=2020-03-17}}</ref>

== References ==
{{reflist}}

[[Category:Companies based in Ahmedabad]]
[[Category:Pharmaceutical companies established in 1951]]
[[Category:Pharmaceutical companies of India]]
[[Category:Indian brands]]
[[Category:1951 establishments in Bombay State]]

Cadila Pharmaceuticals - Revision history

ShermanGraham8: Updated article with clearer structure

imported>Rsrikanth05 at 10:04, 30 August 2021

>Asinolii: /* 1995: Birth of Cadila Pharmaceuticals */